157 related articles for article (PubMed ID: 34536548)
21. Transcriptional regulation of the cyclin-dependent kinase inhibitor, p21
Moussa RS; Kovacevic Z; Bae DH; Lane DJR; Richardson DR
Biochim Biophys Acta Gen Subj; 2018 Mar; 1862(3):761-774. PubMed ID: 29032246
[TBL] [Abstract][Full Text] [Related]
22. Bp44mT: an orally active iron chelator of the thiosemicarbazone class with potent anti-tumour efficacy.
Yu Y; Suryo Rahmanto Y; Richardson DR
Br J Pharmacol; 2012 Jan; 165(1):148-66. PubMed ID: 21658021
[TBL] [Abstract][Full Text] [Related]
23. Iron chelators with high antiproliferative activity up-regulate the expression of a growth inhibitory and metastasis suppressor gene: a link between iron metabolism and proliferation.
Le NT; Richardson DR
Blood; 2004 Nov; 104(9):2967-75. PubMed ID: 15251988
[TBL] [Abstract][Full Text] [Related]
24. The iron-regulated metastasis suppressor NDRG1 targets NEDD4L, PTEN, and SMAD4 and inhibits the PI3K and Ras signaling pathways.
Kovacevic Z; Chikhani S; Lui GY; Sivagurunathan S; Richardson DR
Antioxid Redox Signal; 2013 Mar; 18(8):874-87. PubMed ID: 22462691
[TBL] [Abstract][Full Text] [Related]
25. Targeting cancer by binding iron: Dissecting cellular signaling pathways.
Lui GY; Kovacevic Z; Richardson V; Merlot AM; Kalinowski DS; Richardson DR
Oncotarget; 2015 Aug; 6(22):18748-79. PubMed ID: 26125440
[TBL] [Abstract][Full Text] [Related]
26. Quantitative analysis of the anti-proliferative activity of combinations of selected iron-chelating agents and clinically used anti-neoplastic drugs.
Potuckova E; Jansova H; Machacek M; Vavrova A; Haskova P; Tichotova L; Richardson V; Kalinowski DS; Richardson DR; Simunek T
PLoS One; 2014; 9(2):e88754. PubMed ID: 24586383
[TBL] [Abstract][Full Text] [Related]
27. N-myc oncogene overexpression down-regulates leukemia inhibitory factor in neuroblastoma.
Hatzi E; Murphy C; Zoephel A; Ahorn H; Tontsch U; Bamberger AM; Yamauchi-Takihara K; Schweigerer L; Fotsis T
Eur J Biochem; 2002 Aug; 269(15):3732-41. PubMed ID: 12153570
[TBL] [Abstract][Full Text] [Related]
28. Targeting the metastasis suppressor, NDRG1, using novel iron chelators: regulation of stress fiber-mediated tumor cell migration via modulation of the ROCK1/pMLC2 signaling pathway.
Sun J; Zhang D; Zheng Y; Zhao Q; Zheng M; Kovacevic Z; Richardson DR
Mol Pharmacol; 2013 Feb; 83(2):454-69. PubMed ID: 23188716
[TBL] [Abstract][Full Text] [Related]
29. Cellular iron depletion stimulates the JNK and p38 MAPK signaling transduction pathways, dissociation of ASK1-thioredoxin, and activation of ASK1.
Yu Y; Richardson DR
J Biol Chem; 2011 Apr; 286(17):15413-27. PubMed ID: 21378396
[TBL] [Abstract][Full Text] [Related]
30. Dp44mT, an iron chelator, suppresses growth and induces apoptosis via RORA-mediated NDRG2-IL6/JAK2/STAT3 signaling in glioma.
Zhou J; Jiang Y; Zhao J; Zhang H; Fu J; Luo P; Ma Y; Zou D; Gao H; Hu J; Zhang Y; Jing Z
Cell Oncol (Dordr); 2020 Jun; 43(3):461-475. PubMed ID: 32207044
[TBL] [Abstract][Full Text] [Related]
31. The metastasis suppressor NDRG1 down-regulates the epidermal growth factor receptor via a lysosomal mechanism by up-regulating mitogen-inducible gene 6.
Menezes SV; Kovacevic Z; Richardson DR
J Biol Chem; 2019 Mar; 294(11):4045-4064. PubMed ID: 30679310
[TBL] [Abstract][Full Text] [Related]
32. Novel Thiosemicarbazones Sensitize Pediatric Solid Tumor Cell-Types to Conventional Chemotherapeutics through Multiple Molecular Mechanisms.
Paukovcekova S; Skoda J; Neradil J; Mikulenkova E; Chlapek P; Sterba J; Richardson DR; Veselska R
Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33334021
[TBL] [Abstract][Full Text] [Related]
33. Novel Thiosemicarbazones Inhibit Lysine-Rich Carcinoembryonic Antigen-Related Cell Adhesion Molecule 1 (CEACAM1) Coisolated (LYRIC) and the LYRIC-Induced Epithelial-Mesenchymal Transition via Upregulation of N-Myc Downstream-Regulated Gene 1 (NDRG1).
Xi R; Pun IH; Menezes SV; Fouani L; Kalinowski DS; Huang ML; Zhang X; Richardson DR; Kovacevic Z
Mol Pharmacol; 2017 May; 91(5):499-517. PubMed ID: 28275050
[TBL] [Abstract][Full Text] [Related]
34. The thiosemicarbazone, DpC, broadly synergizes with multiple anti-cancer therapeutics and demonstrates temperature- and energy-dependent uptake by tumor cells.
Dharmasivam M; Azad MG; Afroz R; Richardson V; Jansson PJ; Richardson DR
Biochim Biophys Acta Gen Subj; 2022 Aug; 1866(8):130152. PubMed ID: 35436509
[TBL] [Abstract][Full Text] [Related]
35. Novel and potent anti-tumor and anti-metastatic di-2-pyridylketone thiosemicarbazones demonstrate marked differences in pharmacology between the first and second generation lead agents.
Sestak V; Stariat J; Cermanova J; Potuckova E; Chladek J; Roh J; Bures J; Jansova H; Prusa P; Sterba M; Micuda S; Simunek T; Kalinowski DS; Richardson DR; Kovarikova P
Oncotarget; 2015 Dec; 6(40):42411-28. PubMed ID: 26623727
[TBL] [Abstract][Full Text] [Related]
36. Targeting the Metastasis Suppressor, N-Myc Downstream Regulated Gene-1, with Novel Di-2-Pyridylketone Thiosemicarbazones: Suppression of Tumor Cell Migration and Cell-Collagen Adhesion by Inhibiting Focal Adhesion Kinase/Paxillin Signaling.
Wangpu X; Lu J; Xi R; Yue F; Sahni S; Park KC; Menezes S; Huang ML; Zheng M; Kovacevic Z; Richardson DR
Mol Pharmacol; 2016 May; 89(5):521-40. PubMed ID: 26895766
[TBL] [Abstract][Full Text] [Related]
37. The role of iron in cell cycle progression and the proliferation of neoplastic cells.
Le NT; Richardson DR
Biochim Biophys Acta; 2002 Oct; 1603(1):31-46. PubMed ID: 12242109
[TBL] [Abstract][Full Text] [Related]
38. The Myc Family and the Metastasis Suppressor NDRG1: Targeting Key Molecular Interactions with Innovative Therapeutics.
Deng Z; Richardson DR
Pharmacol Rev; 2023 Sep; 75(5):1007-1035. PubMed ID: 37280098
[TBL] [Abstract][Full Text] [Related]
39. BET inhibition silences expression of MYCN and BCL2 and induces cytotoxicity in neuroblastoma tumor models.
Wyce A; Ganji G; Smitheman KN; Chung CW; Korenchuk S; Bai Y; Barbash O; Le B; Craggs PD; McCabe MT; Kennedy-Wilson KM; Sanchez LV; Gosmini RL; Parr N; McHugh CF; Dhanak D; Prinjha RK; Auger KR; Tummino PJ
PLoS One; 2013; 8(8):e72967. PubMed ID: 24009722
[TBL] [Abstract][Full Text] [Related]
40. The potential of iron chelators of the pyridoxal isonicotinoyl hydrazone class as effective antiproliferative agents III: the effect of the ligands on molecular targets involved in proliferation.
Darnell G; Richardson DR
Blood; 1999 Jul; 94(2):781-92. PubMed ID: 10397746
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]